Arrowhead Pharmaceuticals Aktie
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Arrowhead Pharmaceuticals Aktie Analyse
| 12.02.18 | Arrowhead Pharmaceuticals Neutral | Cantor Fitzgerald | |
| 12.02.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
| 05.01.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
| 30.11.16 | Arrowhead Pharmaceuticals Mkt Perform | William Blair | |
| 30.11.16 | Arrowhead Pharmaceuticals Hold | Cantor Fitzgerald | |
| 30.11.16 | Arrowhead Pharmaceuticals Neutral | Chardan Capital Markets | |
| 09.10.14 | Arrowhead Pharmaceuticals Sector Perform | RBC Capital Markets |